Valuation: Novartis AG

Market Cap 302B 258B 241B 221B 415B 28,863B 424B 2,859B 1,114B 14,465B 1,133B 1,108B 47,889B P/E 2026 *
22.5x
P/E 2027 * 19.2x
Enterprise Value 334B 286B 267B 245B 461B 31,990B 470B 3,168B 1,235B 16,032B 1,255B 1,228B 53,077B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.37x
Free-Float
91.66%
Yield 2026 *
2.76%
Yield 2027 * 2.87%
1 day-0.74%
1 week+2.10%
Current month-0.21%
1 month+2.63%
3 months+6.58%
6 months-0.09%
Current year+15.27%
1 week 121.02
Extreme 121.02
128.26
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 67,000 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%+2.10%+23.43%+40.38% 302B
-2.31%+3.36%+77.14%+127.18% 1,141B
-1.64%+2.71%+50.51%+60.85% 659B
-1.48%+4.99%+25.90%+75.37% 470B
+1.20%+2.62%+41.69%+46.21% 366B
+0.32%+3.25%+0.94%+13.25% 254B
-2.09%+3.70%+46.17%+66.21% 239B
-1.10%-0.70%-14.31%-53.04% 207B
-1.79%+4.85%+22.00%+90.74% 183B
-1.01%+4.57%+10.42%-24.28% 161B
Average -1.08%+3.93%+28.39%+44.29% 398.19B
Weighted average by Cap. -1.37%+4.23%+42.65%+67.98%

Financials

2026 *2027 *
Net sales 57.65B 49.36B 46.05B 42.26B 79.41B 5,516B 80.97B 546B 213B 2,764B 216B 212B 9,152B 61.31B 52.49B 48.98B 44.94B 84.45B 5,866B 86.11B 581B 226B 2,940B 230B 225B 9,733B
Net income 13.95B 11.94B 11.14B 10.23B 19.22B 1,335B 19.59B 132B 51.54B 669B 52.38B 51.24B 2,215B 15.5B 13.27B 12.38B 11.36B 21.35B 1,483B 21.77B 147B 57.27B 743B 58.21B 56.94B 2,461B
Net Debt 32.68B 27.98B 26.11B 23.95B 45.01B 3,127B 45.9B 310B 121B 1,567B 123B 120B 5,188B 27.82B 23.82B 22.22B 20.39B 38.32B 2,662B 39.07B 264B 103B 1,334B 104B 102B 4,416B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
20/08/26 CHF 126.34 -0.61% 1,856,746
19/08/26 CHF 127.12 +1.24% 2,053,740
18/08/26 CHF 125.56 +1.75% 1,794,769
17/08/26 CHF 123.40 +0.78% 1,293,936
14/08/26 CHF 122.44 -1.05% 1,619,121
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
158.70USD
Average target price
154.23USD
Spread / Average Target
-2.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock